Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The clinical evaluation of hirsutism.
Somani N, Harrison S, Bergfeld WF. Somani N, et al. Dermatol Ther. 2008 Sep-Oct;21(5):376-91. doi: 10.1111/j.1529-8019.2008.00219.x. Dermatol Ther. 2008. PMID: 18844715 Review.
Update on the management of hirsutism.
Harrison S, Somani N, Bergfeld WF. Harrison S, et al. Among authors: somani n. Cleve Clin J Med. 2010 Jun;77(6):388-98. doi: 10.3949/ccjm.77a.08079. Cleve Clin J Med. 2010. PMID: 20516250 Free article.
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial.
Paller AS, Seyger MMB, Magariños GA, Pinter A, Cather JC, Rodriguez-Capriles C, Zhu D, Somani N, Garrelts A, Papp KA; IXORA-PEDS Investigators. Paller AS, et al. Among authors: somani n. JAMA Dermatol. 2022 May 1;158(5):533-541. doi: 10.1001/jamadermatol.2022.0655. JAMA Dermatol. 2022. PMID: 35416908 Free PMC article. Clinical Trial.
Higher rates of skin clearance and efficacy in challenging body areas are associated with better health-related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasis.
Hebert AA, Bobonich MA, Rodriguez Capriles C, Gallo G, Li L, Somani N, Ridenour T, Wang Y, Edson-Heredia E, Becker EM. Hebert AA, et al. Among authors: somani n. Pediatr Dermatol. 2022 Jan;39(1):55-60. doi: 10.1111/pde.14892. Epub 2021 Dec 20. Pediatr Dermatol. 2022. PMID: 34931346 Free PMC article.
Comparison of two-year treatment adherence, persistence, discontinuation, reinitiation, and switching between psoriasis patients treated with ixekizumab or secukinumab in real-world settings.
Blauvelt A, Shi N, Somani N, Burge R, Zhu B, Ridenour TL, Lew CR, Zimmerman NM, Atiya B, Murage MJ. Blauvelt A, et al. Among authors: somani n. J Am Acad Dermatol. 2022 Mar;86(3):581-589. doi: 10.1016/j.jaad.2021.06.878. Epub 2021 Jul 9. J Am Acad Dermatol. 2022. PMID: 34252464
54 results